Page last updated: 2024-09-05

arimoclomol and sincalide

arimoclomol has been researched along with sincalide in 1 studies

Compound Research Comparison

Studies
(arimoclomol)
Trials
(arimoclomol)
Recent Studies (post-2010)
(arimoclomol)
Studies
(sincalide)
Trials
(sincalide)
Recent Studies (post-2010) (sincalide)
344224,01572533

Protein Interaction Comparison

ProteinTaxonomyarimoclomol (IC50)sincalide (IC50)
Cholecystokinin receptor type ARattus norvegicus (Norway rat)0.0006
Cholecystokinin receptor type AHomo sapiens (human)0.0006
Gastrin/cholecystokinin type B receptorHomo sapiens (human)0.001
Gastrin/cholecystokinin type B receptorMus musculus (house mouse)0.0008
Cholecystokinin receptor type ACavia porcellus (domestic guinea pig)0.0004

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Boros, I; Iványi, B; Jednákovits, A; Lonovics, J; Németh, I; Rakonczay, Z; Takács, T; Varga, I1

Other Studies

1 other study(ies) available for arimoclomol and sincalide

ArticleYear
Nontoxic heat shock protein coinducer BRX-220 protects against acute pancreatitis in rats.
    Free radical biology & medicine, 2002, Jun-15, Volume: 32, Issue:12

    Topics: Acute Disease; Amylases; Animals; Blotting, Western; Catalase; Chaperonin 60; Glutathione; Glutathione Peroxidase; Heat-Shock Proteins; HSP72 Heat-Shock Proteins; Hydroxylamines; Lipase; Lipid Peroxidation; Male; Pancreas; Pancreatitis; Rabbits; Rats; Rats, Wistar; Sincalide; Superoxide Dismutase; Trypsinogen

2002